COVAX
DEAD

Serial Number

90709359

Owner

GAVI ALLIANCE

Attorney

Pam Kohli Jacobson

First Use Date

Jun 4, 2020

Filing Date

May 13, 2021

Add to watchlist:

No watchlists yet
View on USPTO

COVAX Trademark

Serial Number: 90709359

COVAX is a trademark filed by GAVI ALLIANCE on May 13, 2021. The trademark is classified under Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

GAVI ALLIANCE (11 trademarks)

2, CHEMIN DES MINES
GENEVA CH-1202 , CH

Entity Type: 99

Trademark Details

Filing Date

May 13, 2021

Registration Date

Not Registered

First Use Anywhere

June 4, 2020

First Use in Commerce

June 4, 2020

Goods & Services

Providing on-line articles, publication of texts and journals and digital video publishing services all in the fields of public health, the benefits of vaccines for preventing and treating SARS-COV2, COVID-19, and coronavirus diseases and disorders, the risks of not getting vaccinated to prevent and treat SARS-COV2, COVID-19, and coronavirus diseases and disorders, the health risks of an under-immunized community, and equitable access to vaccines for preventing and treating SARS-COV2, COVID-19, and coronavirus diseases and disorders; educational services, namely, providing training and seminars in the field of vaccines and medicines for preventing and treating SARS-COV2, COVID-19, and coronavirus diseases and disorders; organizing and conducting educational meetings and conferences in the field of vaccines and medicines for preventing and treating SARS-COV2, COVID-19, and coronavirus diseases and disorders; Providing information on-line relating to educational instruction in the field of public health, the benefits of vaccines for preventing and treating SARS-COV2, COVID-19, and coronavirus diseases and disorders, the risks of not getting vaccinated to prevent and treat SARS-COV2, COVID-19, and coronavirus diseases and disorders, the health risks of an under-immunized community, and equitable access to vaccines for preventing and treating SARS-COV2, COVID-19, and coronavirus diseases and disorders

Charitable fund-raising services by means of organizing and conducting fundraising events to promote donations for the purchase and supply of medical goods and services; Financial services, namely, investment of funds for the research, development, manufacture and distribution of vaccines for preventing and treating SARS-COV2, COVID-19, and coronavirus diseases and disorders; insurance services, namely, providing no-fault claim compensation; insurance authorization support, namely, insurance claims processing and providing insurance information

Advertising services, namely, promoting public awareness of public health, the benefits of vaccines for preventing and treating SARS-COV2, COVID-19, and coronavirus diseases and disorders, the risks of not getting vaccinated to prevent and treat SARS-COV2, COVID-19, and coronavirus diseases and disorders, the health risks of an under-immunized community, and equitable access to vaccines for preventing and treating SARS-COV2, COVID-19, and coronavirus diseases and disorders all the foregoing by means of public advocacy; procurement services for others, namely, purchasing vaccines for preventing and treating SARS-COV2, COVID-19, and coronavirus diseases and disorders

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Feb 10, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Feb 10, 2024 ABN2
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 28, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 28, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 28, 2023 REAP
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 15, 2023 GNFN
FINAL REFUSAL E-MAILED
Oct 15, 2023 GNFR
FINAL REFUSAL WRITTEN
Oct 15, 2023 CNFR
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Apr 5, 2023 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 2, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 2, 2022 GNSL
SUSPENSION LETTER WRITTEN
Sep 2, 2022 CNSL
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 2, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 2, 2022 GNSL
SUSPENSION LETTER WRITTEN
Sep 2, 2022 CNSL
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sep 2, 2022 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 25, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Aug 25, 2022 GNSL
SUSPENSION LETTER WRITTEN
Aug 25, 2022 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 22, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 22, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 22, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 22, 2021 GNRN
NON-FINAL ACTION E-MAILED
Dec 22, 2021 GNRT
NON-FINAL ACTION WRITTEN
Dec 22, 2021 CNRT
ASSIGNED TO EXAMINER
Dec 14, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 12, 2021 NWOS
NEW APPLICATION ENTERED
May 17, 2021 NWAP